Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin + megestrol vs megestrol alone for disordered proliferative or hyperplastic endometrium
IRCT201410275283N11Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin and megestrol in endometrial hyperplasia (EH), disordered proliferative endometrium (DPE) and menstrual disorders (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Primary endometrial histologic response. Started Nov 2014; status: completed.
02
Drugs
metforminmegestrol
03
Conditions
endometrial hyperplasia (EH)disordered proliferative endometrium (DPE)menstrual disorders
Beyond the preview
Go deeper on IRCT201410275283N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201410275283N11.